Hadi, Najah <br/><br/>
Vitamin E and telmisartan attenuates doxorubicin induced cardiac injury in rat through down regulation of inflammatory response.  [electronic resource] 

 -  BMC cardiovascular disorders  Aug 2012 
 - 63 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1471-2261 
<br/><br/><label>Standard No.: </label>10.1186/1471-2261-12-63  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents--pharmacology<br/>Antioxidants--pharmacology<br/>Benzimidazoles--pharmacology<br/>Benzoates--pharmacology<br/>Blotting, Western<br/>Cardiac Catheterization<br/>Catalase--blood<br/>Chemokine CCL2--blood<br/>Creatine Kinase, MB Form--blood<br/>Disease Models, Animal<br/>Down-Regulation<br/>Doxorubicin<br/>Enzyme-Linked Immunosorbent Assay<br/>Fluorescent Antibody Technique<br/>Heart Diseases--blood<br/>Inflammation Mediators--blood<br/>Intercellular Adhesion Molecule-1--blood<br/>L-Lactate Dehydrogenase--blood<br/>Macrophages--drug effects<br/>Male<br/>Malondialdehyde--blood<br/>Myocardium--immunology<br/>Oxidative Stress--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Telmisartan<br/>Time Factors<br/>Troponin I--blood<br/>Ventricular Function, Left--drug effects<br/>Vitamin E--pharmacology